Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | FATE |
---|---|---|
09:32 ET | 5652 | 3.52 |
09:34 ET | 2527 | 3.485 |
09:36 ET | 2730 | 3.56 |
09:38 ET | 14773 | 3.62 |
09:39 ET | 3990 | 3.65 |
09:41 ET | 19811 | 3.68 |
09:43 ET | 6245 | 3.685 |
09:45 ET | 4867 | 3.67 |
09:48 ET | 6083 | 3.675 |
09:50 ET | 4895 | 3.645 |
09:52 ET | 1199 | 3.655 |
09:54 ET | 7996 | 3.655 |
09:56 ET | 7680 | 3.655 |
09:57 ET | 4967 | 3.67 |
09:59 ET | 10467 | 3.665 |
10:01 ET | 12418 | 3.645 |
10:03 ET | 11810 | 3.65 |
10:06 ET | 17225 | 3.59 |
10:08 ET | 200 | 3.585 |
10:10 ET | 4411 | 3.55 |
10:12 ET | 2696 | 3.57 |
10:14 ET | 8025 | 3.57 |
10:15 ET | 4008 | 3.595 |
10:17 ET | 1908 | 3.615 |
10:19 ET | 2594 | 3.625 |
10:21 ET | 3205 | 3.625 |
10:24 ET | 10686 | 3.66 |
10:26 ET | 4354 | 3.635 |
10:28 ET | 6266 | 3.625 |
10:30 ET | 2150 | 3.62 |
10:32 ET | 2599 | 3.63 |
10:33 ET | 800 | 3.625 |
10:35 ET | 7467 | 3.615 |
10:37 ET | 3000 | 3.62 |
10:39 ET | 1300 | 3.63 |
10:42 ET | 1800 | 3.62 |
10:44 ET | 1400 | 3.6 |
10:46 ET | 2100 | 3.61 |
10:48 ET | 3140 | 3.5832 |
10:50 ET | 3522 | 3.58 |
10:51 ET | 4659 | 3.6 |
10:53 ET | 4087 | 3.6 |
10:55 ET | 2606 | 3.61 |
10:57 ET | 1724 | 3.6195 |
11:00 ET | 4725 | 3.63 |
11:02 ET | 17463 | 3.62 |
11:04 ET | 11020 | 3.5894 |
11:06 ET | 293 | 3.58 |
11:08 ET | 7786 | 3.585 |
11:09 ET | 3011 | 3.6 |
11:11 ET | 6900 | 3.5999 |
11:13 ET | 2026 | 3.605 |
11:15 ET | 2900 | 3.585 |
11:18 ET | 4034 | 3.59 |
11:20 ET | 1553 | 3.58 |
11:22 ET | 300 | 3.58 |
11:24 ET | 1037 | 3.575 |
11:26 ET | 426 | 3.58 |
11:27 ET | 700 | 3.578 |
11:29 ET | 1661 | 3.575 |
11:31 ET | 4874 | 3.585 |
11:33 ET | 5186 | 3.5845 |
11:36 ET | 626 | 3.585 |
11:38 ET | 800 | 3.585 |
11:40 ET | 1400 | 3.58 |
11:42 ET | 4028 | 3.575 |
11:44 ET | 1740 | 3.58 |
11:45 ET | 2700 | 3.5799 |
11:47 ET | 2112 | 3.585 |
11:49 ET | 800 | 3.59 |
11:51 ET | 800 | 3.59 |
11:54 ET | 4600 | 3.575 |
11:56 ET | 5215 | 3.575 |
12:00 ET | 5030 | 3.56 |
12:02 ET | 1228 | 3.555 |
12:03 ET | 1400 | 3.545 |
12:05 ET | 3632 | 3.555 |
12:07 ET | 2100 | 3.545 |
12:12 ET | 1524 | 3.5499 |
12:14 ET | 2638 | 3.52 |
12:16 ET | 6784 | 3.535 |
12:18 ET | 2014 | 3.54 |
12:20 ET | 2138 | 3.54 |
12:21 ET | 23991 | 3.545 |
12:23 ET | 1334 | 3.54 |
12:25 ET | 100 | 3.535 |
12:27 ET | 1996 | 3.545 |
12:30 ET | 1100 | 3.535 |
12:32 ET | 200 | 3.535 |
12:34 ET | 758 | 3.535 |
12:36 ET | 6952 | 3.535 |
12:38 ET | 725 | 3.535 |
12:39 ET | 1406 | 3.54 |
12:41 ET | 200 | 3.54 |
12:43 ET | 4723 | 3.515 |
12:45 ET | 1200 | 3.52 |
12:48 ET | 1058 | 3.51 |
12:50 ET | 600 | 3.52 |
12:52 ET | 500 | 3.52 |
12:54 ET | 500 | 3.52 |
12:56 ET | 5102 | 3.53 |
12:57 ET | 600 | 3.525 |
12:59 ET | 10509 | 3.52 |
01:01 ET | 100 | 3.52 |
01:03 ET | 5487 | 3.54 |
01:06 ET | 2312 | 3.53 |
01:08 ET | 600 | 3.53 |
01:10 ET | 1416 | 3.53 |
01:12 ET | 3900 | 3.535 |
01:14 ET | 7026 | 3.5332 |
01:15 ET | 300 | 3.54 |
01:17 ET | 1609 | 3.53 |
01:19 ET | 10792 | 3.535 |
01:24 ET | 4072 | 3.545 |
01:26 ET | 600 | 3.55 |
01:28 ET | 8230 | 3.555 |
01:30 ET | 400 | 3.56 |
01:32 ET | 200 | 3.555 |
01:33 ET | 3630 | 3.56 |
01:35 ET | 6171 | 3.55 |
01:37 ET | 200 | 3.55 |
01:39 ET | 600 | 3.54 |
01:42 ET | 4130 | 3.535 |
01:44 ET | 5500 | 3.54 |
01:46 ET | 6608 | 3.55 |
01:48 ET | 1498 | 3.55 |
01:50 ET | 900 | 3.545 |
01:51 ET | 13322 | 3.57 |
01:53 ET | 5465 | 3.56 |
01:55 ET | 635 | 3.56 |
01:57 ET | 200 | 3.56 |
02:00 ET | 420 | 3.56 |
02:02 ET | 42092 | 3.585 |
02:04 ET | 6445 | 3.575 |
02:06 ET | 9762 | 3.58 |
02:08 ET | 6333 | 3.59 |
02:09 ET | 6964 | 3.615 |
02:11 ET | 8903 | 3.61 |
02:13 ET | 2125 | 3.62 |
02:15 ET | 2773 | 3.6 |
02:18 ET | 434 | 3.61 |
02:20 ET | 3306 | 3.615 |
02:22 ET | 700 | 3.615 |
02:24 ET | 9521 | 3.63 |
02:26 ET | 100 | 3.63 |
02:27 ET | 700 | 3.625 |
02:29 ET | 1400 | 3.63 |
02:31 ET | 8210 | 3.615 |
02:33 ET | 7415 | 3.63 |
02:36 ET | 6455 | 3.635 |
02:38 ET | 3205 | 3.64 |
02:40 ET | 3404 | 3.64 |
02:42 ET | 2272 | 3.64 |
02:44 ET | 30560 | 3.645 |
02:45 ET | 13412 | 3.645 |
02:47 ET | 38657 | 3.63 |
02:49 ET | 17142 | 3.635 |
02:51 ET | 4644 | 3.635 |
02:54 ET | 9666 | 3.625 |
02:56 ET | 2300 | 3.63 |
02:58 ET | 15764 | 3.65 |
03:00 ET | 5159 | 3.65 |
03:02 ET | 2304 | 3.65 |
03:03 ET | 9483 | 3.655 |
03:05 ET | 3944 | 3.66 |
03:07 ET | 20715 | 3.65 |
03:09 ET | 1412 | 3.655 |
03:12 ET | 1273 | 3.655 |
03:14 ET | 916 | 3.655 |
03:16 ET | 3587 | 3.65 |
03:18 ET | 1000 | 3.655 |
03:20 ET | 10108 | 3.65 |
03:21 ET | 1200 | 3.65 |
03:23 ET | 1200 | 3.655 |
03:25 ET | 1300 | 3.66 |
03:27 ET | 1392 | 3.66 |
03:30 ET | 13435 | 3.645 |
03:32 ET | 3200 | 3.645 |
03:34 ET | 17784 | 3.665 |
03:36 ET | 1544 | 3.67 |
03:38 ET | 2286 | 3.665 |
03:39 ET | 7793 | 3.66 |
03:41 ET | 6732 | 3.66 |
03:43 ET | 4300 | 3.66 |
03:45 ET | 7052 | 3.67 |
03:48 ET | 10917 | 3.66 |
03:50 ET | 4030 | 3.66 |
03:52 ET | 42748 | 3.68 |
03:54 ET | 9491 | 3.695 |
03:56 ET | 55189 | 3.69 |
03:57 ET | 45362 | 3.68 |
03:59 ET | 97303 | 3.68 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Fate Therapeutics Inc | 392.7M | -1.9x | --- |
Contineum Therapeutics Inc | 385.8M | 20.1x | --- |
ADC Therapeutics SA | 330.9M | -1.2x | --- |
Poseida Therapeutics Inc | 281.2M | -2.5x | --- |
Editas Medicine Inc | 425.2M | -2.5x | --- |
Adaptimmune Therapeutics PLC | 258.1M | -1.6x | --- |
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders. Its proprietary induced pluripotent stem cells (iPSC) product platform combines multiplexed-engineering of human iPSCs with single-cell selection to create clonal master iPSC lines. The Company’s platform is designed to overcome numerous limitations associated with the manufacture of cell therapies using patient- or donor-sourced cells. Utilizing its proprietary iPSC product platform, it is advancing off-the-shelf, multiplexed-engineered natural killer (NK) cell and T-cell product candidates which are selectively designed, incorporate novel synthetic controls of cell function. Its pipeline of iPSC-derived, chimeric antigen receptor (CAR)-targeted NK cell and T-cell product candidates include FT819, FT522, FT576, FT825, FT819, FT522, and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $392.7M |
---|---|
Revenue (TTM) | $6.5M |
Shares Outstanding | 113.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.90 |
EPS | $-1.92 |
Book Value | $3.74 |
P/E Ratio | -1.9x |
Price/Sales (TTM) | 60.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,287.85% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.